Location History:
- Orange, CT (US) (2011 - 2013)
- Dover, MA (US) (2017)
Company Filing History:
3 out of 31 
1 out of 1 Years Active: 2011-2017
Title: Birgitte Binderup Simen: Innovator in HIV Detection Technologies
Introduction
Birgitte Binderup Simen is a notable inventor based in Orange, CT (US). He has made significant contributions to the field of HIV research, particularly in the detection of drug-resistant variants. With a total of 4 patents to his name, Simen's work has the potential to impact the treatment and management of HIV.
Latest Patents
Simen's latest patents include innovative methods for detecting HIV tropism variants and drug-resistant variants. The first patent describes a method for detecting low-frequency occurrences of HIV sequence variants associated with drug resistance. This method involves generating cDNA species from RNA molecules in an HIV sample population, amplifying first amplicons, and determining the nucleic acid sequence composition of immobilized populations. The second patent similarly focuses on detecting low-frequency HIV sequence variants, emphasizing the importance of identifying variants that occur at a frequency of 5% or less.
Career Highlights
Throughout his career, Simen has worked with prominent organizations, including 454 Life Sciences Corporation and 454 Life Sciences, a Roche Company. His experience in these companies has allowed him to develop and refine his innovative approaches to HIV detection.
Collaborations
Some of Simen's notable coworkers include Elizabeth Patricia St John and Christine Lubeski. Their collaborative efforts have contributed to advancements in the field of HIV research.
Conclusion
Birgitte Binderup Simen's work in developing methods for detecting HIV variants showcases his commitment to improving healthcare outcomes. His patents reflect a deep understanding of the complexities of HIV and the need for innovative solutions in the fight against this virus.